Skip to content

Influencing factors and preventive measures of left ventricular aneurysm formation in patients with acute myocardial infarction: a study based on medical records

Influencing factors and preventive measures of left ventricular aneurysm formation in patients with acute myocardial infarction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055374
Enrollment
Unknown
Registered
2022-01-08
Start date
2022-01-17
Completion date
Unknown
Last updated
2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial infarction

Interventions

case series:Drug treatment

Sponsors

Chengde Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for acute STEMI: acute myocardial injury [serum cardiac troponin increased and/or decreased, and at least 1 time was higher than the upper limit of normal (refer to the 99th percentile of the upper limit)], and there was clinical evidence of acute myocardial ischemia; 2. Admission to hospital within 1 week of acute STEMI onset; 3. Patients with transthoracic echocardiography. Ultrasound diagnosis of LVA: (1) Local bulging of the ventricular wall throughout the cardiac cycle; (2) Paradoxical movement of the local chamber wall; (3) Local wall thinning and echo enhancement. Diagnosis of LVT: Ultrasound examination showed an abnormal echo mass with wide base, clear boundary and poor mobility attached to the inner wall of abnormally contracted myocardium in the left ventricle.

Exclusion criteria

Exclusion criteria: 1. STEMI secondary to other heart diseases, such as STEMI caused by coronary spasm, coronary thromboembolism or spontaneous coronary dissection, etc., no obvious obstruction was found in coronary angiography; 2. History of ventricular aneurysm, intracardiac thrombus, blood system disease, malignant tumor, autoimmune disease, atrial fibrillation, dilated cardiomyopathy, hypertrophic cardiomyopathy; 3. During pregnancy; 4. Death occurs in percutaneous coronary intervention (PCI).

Design outcomes

Primary

MeasureTime frame
Demographic characteristics;General clinical information;Medical history;Intervention;Auxiliary examination and treatment;

Countries

China

Contacts

Public ContactLuo Donglei

Chengde Central Hospital

luoyutian999@126.com+86 15933684381

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026